Abstract |
Smart phototheranostic nanomaterials are of significant interest for high-quality imaging and targeted therapy in the precision medicine field. Herein, a nanoscale photosensitizer (NanoPcM) is constructed through the self-assembly of morpholine-substituted silicon phthalocyanine (PcM) and albumin. NanoPcM displays a turn-on fluorescence depending on the acid-induced abolition of the photoinduced electron transfer effect (change in molecular structure) and disassembly of the nanostructure (change in supramolecular structure), which enables low-background and tumor-targeted fluorescence imaging. In addition, its efficient type I photoreaction endows NanoPcM with a superior immunogenic photodynamic therapy ( PDT) effect against solid tumors. The combination of NanoPcM-based PDT and αPD-1-based immunotherapy can efficiently inhibit tumor growth, reduce spontaneous lung metastasis, and trigger abscopal effects. This study should provide a perspective for the future design of nanomaterials as promising phototheranostics for cancer imaging and therapy.
|
Authors | Rui Wang, Kyu-Hwan Kim, Jiyoon Yoo, Xingshu Li, Nahyun Kwon, Yun-Hui Jeon, Suk-Kyung Shin, Seung Seok Han, Dong-Sup Lee, Juyoung Yoon |
Journal | ACS nano
(ACS Nano)
Vol. 16
Issue 2
Pg. 3045-3058
(02 22 2022)
ISSN: 1936-086X [Electronic] United States |
PMID | 35089696
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Albumins
- Isoindoles
- Photosensitizing Agents
- phthalocyanine
|
Topics |
- Albumins
- Cell Line, Tumor
- Fluorescence
- Immunotherapy
- Isoindoles
- Nanostructures
- Photochemotherapy
(methods)
- Photosensitizing Agents
(chemistry, pharmacology, therapeutic use)
|